Smart Dubai partners with Dubai Health Authority to upgrade inventory app

Smart Dubai has partnered with Dubai Health Authority (DHA) to upgrade its ‘Smart Inventory’ application.

The upgrade will enhance the current inventory management system, making it more efficient, while utilising advanced technologies and smart solutions to save time. The project is in line with achieving the objectives of the Dubai Paperless Strategy, it announced on July 28.

The smart inventory app is part of the Government Resource Planning Systems (GRPS), and seeks to manage the stock of medicines in Dubai to prevent any shortages.

The app allows users to process warehousing transactions and track the supply chain for medicines from anywhere using a smartphone, tablet, or any portable device. This also facilitates government entities in Dubai to access inventory in real time.

“Collaborating with our strategic government partners allows us to offer unique services and applications that truly contribute to accelerating Dubai’s full digital transformation,” said Wesam Lootah, CEO, Smart Dubai Government Establishment.

“The Smart Inventory app, which was developed in partnership with the Dubai Health Authority, presents an opportunity for health institutions in Dubai to offer best-in-class services, while optimising the management of their resources. The application also paves the way for achieving the objectives of the Dubai Paperless Strategy by cutting paper consumption in health-related transactions and fully digitising health services.”

Dr. Ali Al Sayed, director of the Pharmaceutical Services Department at DHA said that this step represents an important addition to DHA’s pharmaceutical services.

Smart Inventory’s features allow health authorities to receive, inspect, and hand over medications for every purchase order, in addition to tracking these products and facilitating internal shipments.

The app will help cut paper consumption by 1.2 million sheets annually, reducing transaction time by 30 per cent for all supply operations involving medicines. Entities will also be able to cut costs and streamline operations, which, in turn, serves to regulate workflow at government entities and reduce human errors.